Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,978 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.
Mignogna C, Staropoli N, Botta C, De Marco C, Rizzuto A, Morelli M, Di Cello A, Franco R, Camastra C, Presta I, Malara N, Salvino A, Tassone P, Tagliaferri P, Barni T, Donato G, Di Vito A. Mignogna C, et al. Among authors: franco r. J Ovarian Res. 2016 May 21;9(1):31. doi: 10.1186/s13048-016-0238-7. J Ovarian Res. 2016. PMID: 27209210 Free PMC article.
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes.
Marra M, Salzano G, Leonetti C, Tassone P, Scarsella M, Zappavigna S, Calimeri T, Franco R, Liguori G, Cigliana G, Ascani R, La Rotonda MI, Abbruzzese A, Tagliaferri P, Caraglia M, De Rosa G. Marra M, et al. Among authors: franco r. Nanomedicine. 2011 Dec;7(6):955-64. doi: 10.1016/j.nano.2011.03.004. Epub 2011 Mar 29. Nanomedicine. 2011. PMID: 21453789
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma.
Di Martino MT, Campani V, Misso G, Gallo Cantafio ME, Gullà A, Foresta U, Guzzi PH, Castellano M, Grimaldi A, Gigantino V, Franco R, Lusa S, Cannataro M, Tagliaferri P, De Rosa G, Tassone P, Caraglia M. Di Martino MT, et al. Among authors: franco r. PLoS One. 2014 Feb 27;9(2):e90005. doi: 10.1371/journal.pone.0090005. eCollection 2014. PLoS One. 2014. PMID: 24587182 Free PMC article.
Mutant AKT1-E17K is oncogenic in lung epithelial cells.
De Marco C, Malanga D, Rinaldo N, De Vita F, Scrima M, Lovisa S, Fabris L, Carriero MV, Franco R, Rizzuto A, Baldassarre G, Viglietto G. De Marco C, et al. Among authors: franco r. Oncotarget. 2015 Nov 24;6(37):39634-50. doi: 10.18632/oncotarget.4022. Oncotarget. 2015. PMID: 26053093 Free PMC article.
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells.
Malanga D, De Marco C, Guerriero I, Colelli F, Rinaldo N, Scrima M, Mirante T, De Vitis C, Zoppoli P, Ceccarelli M, Riccardi M, Ravo M, Weisz A, Federico A, Franco R, Rocco G, Mancini R, Rizzuto A, Gulletta E, Ciliberto G, Viglietto G. Malanga D, et al. Among authors: franco r. Oncotarget. 2015 Dec 15;6(40):42667-86. doi: 10.18632/oncotarget.5626. Oncotarget. 2015. PMID: 26486080 Free PMC article.
A new look at the ALK gene in cancer: copy number gain and amplification.
Zito Marino F, Rocco G, Morabito A, Mignogna C, Intartaglia M, Liguori G, Botti G, Franco R. Zito Marino F, et al. Among authors: franco r. Expert Rev Anticancer Ther. 2016 May;16(5):493-502. doi: 10.1586/14737140.2016.1162098. Epub 2016 Apr 6. Expert Rev Anticancer Ther. 2016. PMID: 26943457 Review.
Aberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients.
Scrima M, Zito Marino F, Oliveira DM, Marinaro C, La Mantia E, Rocco G, De Marco C, Malanga D, De Rosa N, Rizzuto A, Botti G, Franco R, Zoppoli P, Viglietto G. Scrima M, et al. Among authors: franco r. J Cancer. 2017 Jan 15;8(2):227-239. doi: 10.7150/jca.17093. eCollection 2017. J Cancer. 2017. PMID: 28243327 Free PMC article.
1,978 results